In this issue:
LDL promotes microvascular thrombosis by enhancing VWF coagulation
Bosentan prevents thromboembolic events in patients with COVID-19
Concomitant NSAIDs and hormonal contraception may increase risk of VTE
Underprescription of anticoagulants for AF in the Netherlands
Andexanet alfa superior to 4F-PCC for treating factor Xa inhibitorrelated bleeds
Promising preclinical results for a novel nonfactor therapy for haemophilia
High prevalence of thrombocytopenia in patients with CAT
Microcirculatory health impacts procoagulant status, especially in women
Risk of ICH in patients with VTE and active brain cancer
Secondary prophylaxis with low-dose DOAC viable in onco-hematologic patients
Favourable long-term outcome in VITT
Please login below to download this issue (PDF)